New Delhi: Pharmaceutical giant AstraZeneca has announced the global withdrawal of its Covid-19 vaccine. The company cited a surplus of newer vaccine options as the primary reason behind this decision.
AstraZeneca has voluntarily withdrawn the “marketing authorization” for the vaccine within the European Union, with similar applications expected to be made in other countries where the vaccine was previously approved.
This decision comes amidst ongoing legal battles faced by AstraZeneca, including allegations linking its vaccine, developed in collaboration with the University of Oxford, to fatalities and severe injuries, notably Thrombosis with Thrombocytopenia Syndrome (TTS).
However, the company has clarified that the withdrawal is not directly linked to ongoing court cases or its admission of TTS side effects. Instead, AstraZeneca attributed the decision to commercial reasons and a decline in demand for the vaccine.
“As multiple variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines,” stated AstraZeneca in a released statement.
Bhubaneswar: The Odisha Government intensified its efforts to strengthen the Mission Shakti ecosystem by launching…
Puri: With the annual Rath Yatra expected to draw lakhs of devotees from across the…
Bhubaneswar: Seeking to amplify the voices and achievements of persons with disabilities through the power…
Bhubaneswar: With extreme weather events posing growing challenges to Odisha, the state government has decided…
Bhubaneswar: The Odisha State Police Housing & Welfare Corporation Limited (OPHWC) has recorded its highest-ever…
Bhubaneswar: Odisha is stepping up efforts to make sanitation work safer and more dignified by…
